Back

Short- and long-term effects of beta-blockers on symptoms of anxiety and depression in patients with myocardial infarction and preserved left ventricular function: prespecified substudy from REDUCE-AM

30 August 2024 (08:00 - 17:30)
Organised by: Logo
Congress Presentation Part of: Smaller trials, trial updates, and other studies on coronary artery disease Beta-Blockers ESC Professional Premium Access ESC Congress 2024 European Society of Cardiology

About the speaker

Photo
Mr Philip Leissner

Uppsala University, Uppsala (Sweden)

7 More presentations in this session

Presentation thumbnail
Effects of Beta-Blockers on Quality of Life and Well-being in Patients with Myocardial Infarction and Preserved Left Ventricular Function - a prespecified substudy from REDUCE-AMI
Associate Professor R. Hofmann (Stockholm, SE)
Slides Video
Presentation thumbnail
Coronary computed tomography angiography guided management of patients with stable chest pain: 10-year outcomes from the SCOT-HEART trial
Professor M. Williams (Edinburgh, GB)
Slides Video
Presentation thumbnail
Adherence to Nordic and Mediterranean dietary patterns may be associated with a lower absolute risk of incident atherosclerotic cardiovascular disease
Doctor C. Bork (Aalborg, DK)
Slides Video
Presentation thumbnail
Cardiorenal effects and safety of initiation of empagliflozin after acute myocardial infarction
Professor D. Bhatt (New York City, US)
Slides Video
Presentation thumbnail
Cardiovascular Risk Scoring or CT Angiography for Lifestyle and Risk Factor Modification in Primary Prevention of Cardiovascular Disease The SCOT-HEART 2 IMPACT Study
Doctor M. Mcdermott (Edinburgh, GB)
Slides Video

Access the full session

Session thumbnail
Smaller trials, trial updates, and other studies on coronary artery disease
Video

The Event

Event poster

ESC Congress 2024

30 August - 2 September 2024
You may be interested in
thumbnail
Webinar
Are beta-blockers still indicated after myocardial infarction?
thumbnail
Congress Presentation
Impact of beta-blocker therapy in patients with preserved left ventricular ejection fraction after ST-segment elevation myocardial infarction
thumbnail
Congress Presentation
Beta-blocker use and outcomes in patients with heart failure and mildly reduced and preserved ejection fraction

ESC 365 is supported by

novartis Explore sponsored resources

ESC 365 is supported by

novartis Explore sponsored resources